Hunter Perkins Capital Management’s Pfizer PFE Stock Holding History

Hunter Perkins Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,036	Closed	-$258K	–	136
2023 Q2	$258K	Sell	7,036 -300	-4%	-$11.7K	0.06%	114
2023 Q1	$299K	Sell	7,336 -330	-4%	-$14.3K	0.07%	97
2022 Q4	$392K	Hold	7,666	–	–	0.09%	78
2022 Q3	$335K	Hold	7,666	–	–	0.08%	75
2022 Q2	$402K	Hold	7,666	–	–	0.09%	68
2022 Q1	$397K	Buy	7,666 +754	+11%	+$39.1K	0.08%	66
2021 Q4	$408K	Buy	+6,912	New	+$342K	0.08%	65
2021 Q1	–	Sell	-29,300	Closed	-$1.08M	–	149
2020 Q4	$1.08M	Buy	+29,300	New	+$1.07M	0.19%	81

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hunter Perkins Capital Management's PFE Position: Q3 2023 in Review

Hunter Perkins Capital Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 7,036 shares — an estimated $258K sold.

Hunter Perkins Capital Management first reported a position in PFE in Q4 2020 and held it in 8 quarters. The position peaked at $1.08M in Q4 2020. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Hunter Perkins Capital Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Hunter Perkins Capital Management sold 7,036 Pfizer shares in Q3 2023, an estimated $258K.
Hunter Perkins Capital Management first reported a position in Pfizer in Q4 2020 and held it in 8 quarters.
Hunter Perkins Capital Management's Pfizer position peaked at $1.08M in Q4 2020.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Hunter Perkins Capital Management's 13F filing for Q3 2023, filed 19 Oct 2023.